The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NADOM trial: Neoadjuvant/adjuvant trial of darovasertib in ocular melanoma (OM).
 
Roderick O'day
No Relationships to Disclose
 
Max Conway
No Relationships to Disclose
 
Li-Anne Lim
No Relationships to Disclose
 
John McKenzie
No Relationships to Disclose
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Nektar; Novartis; Pierre Fabre; Provectus Biopharmaceuticals; QBiotics
Consulting or Advisory Role - Bristol-Myers Squibb; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; QBiotics
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Expert Testimony - Bristol-Myers Squibb/Celgene
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; OncoSec; Pierre Fabre
 
William Glasson
No Relationships to Disclose
 
Lindsay McGrath
No Relationships to Disclose
 
Svetlana Cherepanoff
No Relationships to Disclose
 
Elin Gray
No Relationships to Disclose
 
Matthew A. Maurer
Employment - IDEAYA Biosciences
Stock and Other Ownership Interests - BMS GmbH & Co. KG; IDEAYA Biosciences
Patents, Royalties, Other Intellectual Property - IDEAYA Biosciences
 
Michael O'Quigley
Employment - IDEAYA Biosciences
Stock and Other Ownership Interests - IDEAYA Biosciences
Patents, Royalties, Other Intellectual Property - IDEAYA Biosciences
 
Mark J. Shackleton
No Relationships to Disclose
 
Anthony M. Joshua
Stock and Other Ownership Interests - Pricilium Therapeutics
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); IDEAYA Biosciences (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Merck Serono (Inst); Neoleukin Therapeutics (Inst); Novartis (Inst); Noxopharm (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Cancer therapeutic methods